Classic studies have confirmed that high plasma levels of PAI-1 are associated with an increased risk of cardiovascular diseases [64, 65], and SERPINE1 allelic variations are also associated with the pathogenesis of metabolic syndrome, insulin resistance, and diabetes [66–68]. The gene discussed is SERPINE1; the disease is Insulin resistance.